{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T20:49:28Z","timestamp":1793566168958,"version":"4.5.0"},"reference-count":61,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,12,8]],"date-time":"2022-12-08T00:00:00Z","timestamp":1670457600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006109","name":"Vedeck\u00e1 Grantov\u00e1 Agent\u00fara M\u0160VVa\u0160 SR a SAV","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006109","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005357","name":"Agent\u00fara na Podporu V\u00fdskumu a V\u00fdvoja","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005357","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006109","name":"Vedeck\u00e1 Grantov\u00e1 Agent\u00fara M\u0160VVa\u0160 SR a SAV","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006109","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007594","name":"Univerzita Komensk\u00e9ho v Bratislave","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007594","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015352","name":"Farmaceutick\u00e1 fakulta, Univerzita Komensk\u00e9ho v Bratislave","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015352","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Quercetin (Que) is a potent anti-inflammatory and antioxidant flavonoid with cardioprotective potential. However, very little is known about the signaling pathways and gene regulatory proteins Que may interfere with, especially in diabetic cardiomyopathy. Therefore, we aimed to study the potential cardioprotective effects of Que on the cardiac phenotype of type 2 diabetes mellitus (T2DM) accompanied by obesity.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>For this experiment, we used Zucker Diabetic Fatty rats (fa\/fa) and their age-matched lean controls (fa\/+) that were treated with either vehicle or 20 mg\/kg\/day of Que for 6 weeks. Animals underwent echocardiographic (echo) examination before the first administration of Que and after 6 weeks. <\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>After the initial echo examination, the diabetic rats showed increased E\/A ratio, a marker of left ventricular (LV) diastolic dysfunction, in comparison to the control group which was selectively reversed by Que. Following the echo analysis, Que reduced LV wall thickness and exhibited an opposite effect on LV luminal area. In support of these results, the total collagen content measured by hydroxyproline assay was decreased in the LVs of diabetic rats treated with Que. The follow-up immunoblot analysis of proteins conveying cardiac remodeling pathways revealed that Que was able to interfere with cardiac pro-hypertrophic signaling. In fact, Que reduced relative protein expression of pro-hypertrophic transcriptional factor MEF2 and its counter-regulator HDAC4 along with pSer<jats:sup>246<\/jats:sup>-HDAC4. Furthermore, Que showed potency to decrease GATA4 transcription factor, NFAT3 and calcineurin, as well as upstream extracellular signal-regulated kinase Erk5 which orchestrates several pro-hypertrophic pathways.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>In summary, we showed for the first time that Que ameliorated pro-hypertrophic signaling on the level of epigenetic regulation and targeted specific upstream pathways which provoked inhibition of pro-hypertrophic signals in ZDF rats. Moreover, Que mitigated T2DM and obesity-induced diastolic dysfunction, therefore, might represent an interesting target for future research on novel cardioprotective agents.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2022.1029750","type":"journal-article","created":{"date-parts":[[2022,12,8]],"date-time":"2022-12-08T04:50:14Z","timestamp":1670475014000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":20,"title":["Quercetin alleviates diastolic dysfunction and suppresses adverse pro-hypertrophic signaling in diabetic rats"],"prefix":"10.3389","volume":"13","author":[{"given":"Linda","family":"Bartosova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Csaba","family":"Horvath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Galis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Ferenczyova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbora","family":"Kalocayova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Szobi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Duris-Adameova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Bartekova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Rajtik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,12,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s11892-021-01407-2","article-title":"Asymptomatic diabetic cardiomyopathy: An underrecognized entity in type 2 diabetes","volume":"21","author":"Stanton","year":"2021","journal-title":"Curr Diabetes Rep"},{"key":"B2","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3390\/diagnostics9030121","article-title":"Left ventricular diastolic dysfunction in type 2 diabetes-progress and perspectives","volume":"9","author":"Grigorescu","year":"2019","journal-title":"Diagnostics (Basel)"},{"key":"B3","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s12933-017-0504-z","article-title":"Obesity and type 2 diabetes have additive effects on left ventricular remodelling in normotensive patients-a cross sectional study","volume":"16","author":"De Jong","year":"2017","journal-title":"Cardiovasc Diabetol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/1475-2840-13-89","article-title":"High glucose induces smad activation via the transcriptional coregulator p300 and contributes to cardiac fibrosis and hypertrophy","volume":"13","author":"Bugyei-Twum","year":"2014","journal-title":"Cardiovasc Diabetol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1161\/CIRCULATIONAHA.107.728550","article-title":"Diastolic stiffness of the failing diabetic heart: importance of fibrosis, advanced glycation end products, and myocyte resting tension","volume":"117","author":"van Heerebeek","year":"2008","journal-title":"Circulation"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.0000072977.86706.23","article-title":"Roles of cardiac transcription factors in cardiac hypertrophy","volume":"92","author":"Akazawa","year":"2003","journal-title":"Circ Res"},{"key":"B7","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.biocel.2015.10.012","article-title":"Inhibition of MEF2A prevents hyperglycemia-induced extracellular matrix accumulation by blocking akt and TGF-\u03b21\/Smad activation in cardiac fibroblasts","volume":"69","author":"Chen","year":"2015","journal-title":"Int J Biochem Cell Biol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1161\/CIRCRESAHA.111.258285","article-title":"Hyperamylinemia contributes to cardiac dysfunction in obesity and diabetes: A study in humans and rats","volume":"110","author":"Despa","year":"2012","journal-title":"Circ Res"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.8842","article-title":"Inhibition of myocyte-specific enhancer factor 2A improved diabetic cardiac fibrosis partially by regulating endothelial-to-mesenchymal transition","volume":"7","author":"Chen","year":"2016","journal-title":"Oncotarget"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00029.2008","article-title":"Regulation of cardiomyocyte hypertrophy in diabetes at the transcriptional level","volume":"294","author":"Feng","year":"2008","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1172\/JCI33255","article-title":"The MEF2D transcription factor mediates stress-dependent cardiac remodeling in mice","volume":"118","author":"Kim","year":"2008","journal-title":"J Clin Invest"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1172\/JCI27438","article-title":"CaM kinase II selectively signals to histone deacetylase 4 during cardiomyocyte hypertrophy","volume":"116","author":"Backs","year":"2006","journal-title":"J Clin Invest"},{"key":"B13","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s12933-018-0754-4","article-title":"Regulation of diabetic cardiomyopathy by caloric restriction is mediated by intracellular signaling pathways involving 'SIRT1 and PGC-1\u03b1'","volume":"17","author":"Waldman","year":"2018","journal-title":"Cardiovasc Diabetol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1161\/01.RES.0000197782.21444.8f","article-title":"Control of cardiac growth by histone acetylation\/deacetylation","volume":"98","author":"Backs","year":"2006","journal-title":"Circ Res"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)81573-1","article-title":"A calcineurin-dependent transcriptional pathway for cardiac hypertrophy","volume":"93","author":"Molkentin","year":"1998","journal-title":"Cell"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.0000215985.18538.c4","article-title":"Cardiac-specific deletion of Gata4 reveals its requirement for hypertrophy, compensation, and myocyte viability","volume":"98","author":"Oka","year":"2006","journal-title":"Circ Res"},{"key":"B17","doi-asserted-by":"publisher","first-page":"7285","DOI":"10.3390\/molecules26237285","article-title":"N-acetyl cysteine, selenium, and ascorbic acid rescue diabetic cardiac hypertrophy via mitochondrial-associated redox regulators","volume":"26","author":"Mushtaq","year":"2021","journal-title":"Molecules"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3920\/BM2020.0094","article-title":"Probiotic escherichia coli nissle inhibits IL-6 and MAPK-mediated cardiac hypertrophy during STZ-induced diabetes in rats","volume":"12","author":"Chiang","year":"2021","journal-title":"Benef Microbes"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1152\/japplphysiol.00184.2019","article-title":"Deep ocean minerals inhibit IL-6 and IGFIIR hypertrophic signaling pathways to attenuate diabetes-induced hypertrophy in rat hearts","volume":"127","author":"Lu","year":"2019","journal-title":"J Appl Physiol (1985)"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.109.209320","article-title":"Targeted deletion of the extracellular signal-regulated protein kinase 5 attenuates hypertrophic response and promotes pressure overload-induced apoptosis in the heart","volume":"106","author":"Kimura","year":"2010","journal-title":"Circ Res"},{"key":"B21","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/j.ejmech.2018.06.053","article-title":"Therapeutic potential of quercetin as a cardiovascular agent","volume":"155","author":"Patel","year":"2018","journal-title":"Eur J Med Chem"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.3390\/ijms21051585","article-title":"Potential implications of quercetin and its derivatives in cardioprotection","volume":"21","author":"Ferenczyova","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S277377","article-title":"Effect of quercetin-loaded mesoporous silica nanoparticles on myocardial ischemia-reperfusion injury in rats and its mechanism","volume":"16","author":"Liu","year":"2021","journal-title":"Int J Nanomed"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1139\/Y10-025","article-title":"Acute treatment with polyphenol quercetin improves postischemic recovery of isolated perfused rat hearts after global ischemia","volume":"88","author":"Bartekov\u00e1","year":"2010","journal-title":"Can J Physiol Pharmacol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3390\/ijms16048168","article-title":"Quercetin improves postischemic recovery of heart function in doxorubicin-treated rats and prevents doxorubicin-induced matrix metalloproteinase-2 activation and apoptosis induction","volume":"16","author":"Bartekov\u00e1","year":"2015","journal-title":"Int J Mol Sci"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/jbt.21832","article-title":"Molecular and biochemical evidence on the protective effects of quercetin in isoproterenol-induced acute myocardial injury in rats","volume":"31","author":"Kumar","year":"2017","journal-title":"J Biochem Mol Toxicol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-020-01953-8","article-title":"Quercetin treatment increases H(2)O(2) removal by restoration of endogenous antioxidant activity and blocks isoproterenol-induced cardiac hypertrophy","volume":"394","author":"de Lacerda Alexandre","year":"2021","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.739615","article-title":"Quercetin attenuates cardiac hypertrophy by inhibiting mitochondrial dysfunction through SIRT3\/PARP-1 pathway","volume":"12","author":"Chen","year":"2021","journal-title":"Front Pharmacol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"187","DOI":"10.3390\/molecules25010187","article-title":"Quercetin exerts age-dependent beneficial effects on blood pressure and vascular function, but is inefficient in preventing myocardial ischemia-reperfusion injury in zucker diabetic fatty rats","volume":"25","author":"Ferenczyova","year":"2020","journal-title":"Molecules"},{"key":"B30","doi-asserted-by":"publisher","first-page":"4868","DOI":"10.3390\/molecules26164868","article-title":"Beneficial effect of quercetin on erythrocyte properties in type 2 diabetic rats","volume":"26","author":"Jasenovec","year":"2021","journal-title":"Molecules"},{"key":"B31","doi-asserted-by":"publisher","first-page":"4457","DOI":"10.3390\/ijms22094457","article-title":"Matrix metalloproteinases and their role in mechanisms underlying effects of quercetin on heart function in aged zucker diabetic fatty rats","volume":"22","author":"Bo\u0165ansk\u00e1","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B32","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s12967-017-1189-5","article-title":"Analysis of necroptotic proteins in failing human hearts","volume":"15","author":"Szobi","year":"2017","journal-title":"J Trans Med"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.14536","article-title":"Different signalling in infarcted and non-infarcted areas of rat failing hearts: A role of necroptosis and inflammation","volume":"23","author":"Lich\u00fd","year":"2019","journal-title":"J Cell Mol Med"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardiores.2004.01.021","article-title":"Calcineurin-NFAT signaling regulates the cardiac hypertrophic response in coordination with the MAPKs","volume":"63","author":"Molkentin","year":"2004","journal-title":"Cardiovasc Res"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/19.9.2046","article-title":"GATA-dependent recruitment of MEF2 proteins to target promoters","volume":"19","author":"Morin","year":"2000","journal-title":"EMBO J"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2014.00059","article-title":"Mechanisms of CaMKII activation in the heart","volume":"5","author":"Erickson","year":"2014","journal-title":"Front Pharmacol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"24049","DOI":"10.1038\/srep24049","article-title":"Quercetin, a natural flavonoid interacts with DNA, arrests cell cycle and causes tumor regression by activating mitochondrial pathway of apoptosis","volume":"6","author":"Srivastava","year":"2016","journal-title":"Sci Rep"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2017.03.036","article-title":"Genetic variation in kruppel like factor 15 is associated with left ventricular hypertrophy in patients with type 2 diabetes: Discovery and replication cohorts","volume":"18","author":"Patel","year":"2017","journal-title":"EBioMedicine"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.14740\/jocmr2050w","article-title":"Left ventricular diastolic function in hypertension: Methodological considerations and clinical implications","volume":"7","author":"Palmiero","year":"2015","journal-title":"J Clin Med Res"},{"key":"B40","article-title":"Effect of quercetin on parameters of central hemodynamics and myocardial ischemia in patients with stable coronary heart disease","volume":"70","author":"Chekalina","year":"2017","journal-title":"Wiad Lek"},{"key":"B41","doi-asserted-by":"publisher","first-page":"7239123","DOI":"10.1155\/2018\/7239123","article-title":"Quercetin prevents diastolic dysfunction induced by a high-cholesterol diet: Role of oxidative stress and bioenergetics in hyperglycemic rats","volume":"2018","author":"Castillo","year":"2018","journal-title":"Oxid Med Cell Longev"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1139\/y05-009","article-title":"Partial reversal by rutin and quercetin of impaired cardiac function in streptozotocin-induced diabetic rats","volume":"83","author":"Krishna","year":"2005","journal-title":"Can J Physiol Pharmacol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s10557-018-6771-4","article-title":"Quercetin prevents In vivo and In vitro myocardial hypertrophy through the proteasome-GSK-3 pathway","volume":"32","author":"Chen","year":"2018","journal-title":"Cardiovasc Drugs Ther"},{"key":"B44","doi-asserted-by":"publisher","first-page":"107863","DOI":"10.1016\/j.pharmthera.2021.107863","article-title":"The natriuretic peptide system in heart failure: Diagnostic and therapeutic implications","volume":"227","author":"Kuwahara","year":"2021","journal-title":"Pharmacol Ther"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1093\/eurjhf\/hfq119","article-title":"Slightly elevated b-type natriuretic peptide levels in a non-heart failure range indicate a worse left ventricular diastolic function in individuals with, as compared with individuals without, type 2 diabetes: the hoorn study","volume":"12","author":"van den Hurk","year":"2010","journal-title":"Eur J Heart Fail"},{"key":"B46","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1093\/eurjhf\/hfr166","article-title":"Long-term severe diabetes only leads to mild cardiac diastolic dysfunction in zucker diabetic fatty rats","volume":"14","author":"Daniels","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2020.603247","article-title":"The impact of antidiabetic therapies on diastolic dysfunction and diabetic cardiomyopathy","volume":"11","author":"Gopal","year":"2020","journal-title":"Front Physiol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"226","DOI":"10.3390\/pharmaceutics14020226","article-title":"Cardioprotective role of BGP-15 in ageing zucker diabetic fatty rat (ZDF) model: Extended mitochondrial longevity","volume":"14","author":"Kozma","year":"2022","journal-title":"Pharmaceutics"},{"key":"B49","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1475-2840-8-16","article-title":"Diabetic cardiomyopathy: effects of fenofibrate and metformin in an experimental model\u2013the zucker diabetic rat","volume":"8","author":"Forcheron","year":"2009","journal-title":"Cardiovasc Diabetol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1080\/15384101.2021.1932029","article-title":"Quercetin prevents isoprenaline-induced myocardial fibrosis by promoting autophagy via regulating miR-223-3p\/FOXO3","volume":"20","author":"Hu","year":"2021","journal-title":"Cell Cycle"},{"key":"B51","doi-asserted-by":"publisher","first-page":"8875729","DOI":"10.1155\/2021\/8875729","article-title":"Quercetin reverses cardiac systolic dysfunction in mice fed with a high-fat diet: Role of angiogenesis","volume":"2021","author":"Yu","year":"2021","journal-title":"Oxid Med Cell Longev"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.746382","article-title":"Left ventricular hypertrophy in diabetic cardiomyopathy: A target for intervention","volume":"8","author":"Mohan","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-2952(03)00151-5","article-title":"Evidence of covalent binding of the dietary flavonoid quercetin to DNA and protein in human intestinal and hepatic cells","volume":"65","author":"Walle","year":"2003","journal-title":"Biochem Pharmacol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1186\/s12864-019-5966-9","article-title":"Genome-wide localization of the polyphenol quercetin in human monocytes","volume":"20","author":"Atrahimovich","year":"2019","journal-title":"BMC Genomics"},{"key":"B55","doi-asserted-by":"publisher","first-page":"346","DOI":"10.3390\/molecules24020346","article-title":"Application of pH-responsive Fucoidan\/Chitosan nanoparticles to improve oral quercetin delivery","volume":"24","author":"Barbosa","year":"2019","journal-title":"Molecules"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.679655","article-title":"Histone deacetylases in the pathogenesis of diabetic cardiomyopathy","volume":"12","author":"Ke","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B57","doi-asserted-by":"publisher","first-page":"1600744","DOI":"10.1002\/mnfr.201600744","article-title":"Targeting the epigenome: Screening bioactive compounds that regulate histone deacetylase activity","volume":"61","author":"Godoy","year":"2017","journal-title":"Mol Nutr Food Res"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1002\/tox.23360","article-title":"Leu(27) IGF-II-induced hypertrophy in H9c2 cardiomyoblasts is ameliorated by saffron by regulation of calcineurin\/NFAT and CaMKII\u03b4 signaling","volume":"36","author":"Lin","year":"2021","journal-title":"Environ Toxicol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"3633","DOI":"10.1038\/s41598-019-40002-0","article-title":"TGR5 activation ameliorates hyperglycemia-induced cardiac hypertrophy in H9c2 cells","volume":"9","author":"Cheng","year":"2019","journal-title":"Sci Rep"},{"key":"B60","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1038\/s41467-017-00664-8","article-title":"Metabolic stress-induced cardiomyopathy is caused by mitochondrial dysfunction due to attenuated Erk5 signaling","volume":"8","author":"Liu","year":"2017","journal-title":"Nat Commun"},{"key":"B61","doi-asserted-by":"publisher","first-page":"7226","DOI":"10.3390\/ijms21197226","article-title":"Preventive effects of quercetin against the onset of atherosclerosis-related acute aortic syndromes in mice","volume":"21","author":"Kondo","year":"2020","journal-title":"Int J Mol Sci"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.1029750\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,8]],"date-time":"2022-12-08T04:50:18Z","timestamp":1670475018000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.1029750\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,8]]},"references-count":61,"alternative-id":["10.3389\/fendo.2022.1029750"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2022.1029750","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,8]]},"article-number":"1029750"}}